Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 25.54
-0.26 (-1.01%)
At close: Jan 22, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 201.4 million as of January 23, 2026. Its market cap has increased by 113.10% in one year.
Market Cap
201.40M
Enterprise Value
176.24M
Revenue
30.61M
Ranking
n/a
PE Ratio
37.86
Stock Price
25.54
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 201.40M, an increase of 521.62%. That is a compound annual growth rate of 10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 201.40M | 0.80% |
| Dec 31, 2025 | 199.80M | 111.40% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.32B |
| Krebs Biochemicals & Industries | 1.32B |
| Tyche Industries | 1.13B |
| Resonance Specialties | 1.09B |
| Bacil Pharma | 616.32M |
| Vasundhara Rasayans | 451.78M |
| Supha Pharmachem | 342.72M |
| Crestchem | 264.00M |